Cardlytics (CDLX) Income from Continuing Operations (2017 - 2025)
Historic Income from Continuing Operations for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to -$72.7 million.
- Cardlytics' Income from Continuing Operations rose 4994.35% to -$72.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$110.8 million, marking a year-over-year increase of 5963.32%. This contributed to the annual value of -$189.3 million for FY2024, which is 4053.54% down from last year.
- Per Cardlytics' latest filing, its Income from Continuing Operations stood at -$72.7 million for Q3 2025, which was up 4994.35% from -$9.3 million recorded in Q2 2025.
- In the past 5 years, Cardlytics' Income from Continuing Operations ranged from a high of $33.0 million in Q1 2022 and a low of -$378.3 million during Q4 2022
- Its 5-year average for Income from Continuing Operations is -$53.3 million, with a median of -$24.0 million in 2023.
- Examining YoY changes over the last 5 years, Cardlytics' Income from Continuing Operations showed a top increase of 23270.94% in 2022 and a maximum decrease of 309627.38% in 2022.
- Quarter analysis of 5 years shows Cardlytics' Income from Continuing Operations stood at -$11.8 million in 2021, then crashed by 3096.27% to -$378.3 million in 2022, then skyrocketed by 73.34% to -$100.8 million in 2023, then surged by 84.54% to -$15.6 million in 2024, then tumbled by 366.18% to -$72.7 million in 2025.
- Its Income from Continuing Operations stands at -$72.7 million for Q3 2025, versus -$9.3 million for Q2 2025 and -$13.3 million for Q1 2025.